AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (January 15, 2004). doi:10.1152/ajpheart.00778.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/H2057    most recent
00778.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by L'Ecuyer, T. J.
Right arrow Articles by Vander Heide, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by L'Ecuyer, T. J.
Right arrow Articles by Vander Heide, R.
Submitted on August 13, 2003
Accepted on January 13, 2004

Glutathione-S-transferase overexpression protects against anthracycline-induced H9C2 cell death

Thomas J. L'Ecuyer1*, Zuhair Allebban2, Ronald Thomas1, and Richard Vander Heide3

1 Department of Pediatrics, Wayne State University, Detroit, Michigan, USA
2 Department of Pathology, Wayne State University, Detroit, Michigan, USA
3 Department of Pathology, Wayne State University, Detroit, Michigan, USA; Department of Pathology, John D. Dingell Department of Veterans Affairs Medical Center, Detroit, Michigan, USA

* To whom correspondence should be addressed. E-mail: thlecuye{at}med.wayne.edu.

Anthracyclines (AC) are anti-tumor antibiotics with significant activity against solid and hematologic malignancies. One problem preventing more widespread use has been the development of cardiac toxicity. Experimental evidence supports oxidant stress as an important trigger and/or mediator of AC-induced cardiotoxicity (ACT). Therefore, reducing oxidant stress should be protective against ACT. To determine whether antioxidant protein overexpression can reduce ACT, we developed a cell culture model system using the H9C2 cardiac cell line exhibiting controlled overexpression of the a4 isoform of glutathione transferase (GST). Treatment with the AC doxorubicin (DOX) produced both oncosis, manifested by an increase in the number of cells staining positive for trypan blue, and apoptosis, indicated by the presence of positive deoxynucleotidyl transferase (TUNEL) staining. In both cases, the loss of cell viability was preceded by an AC-induced increase in fluorescence with carboxy-dichlorofluorescein diacetate (DFDA), demonstrating the presence of high levels of reactive oxygen species (ROS). The DOX-induced increase in ROS was reduced to control levels by maximal GSToverexpression. Coincident with this elimination of oxidative stress, there was a reduction in both trypan-blue and TUNEL-positive cells, indicating that GST overexpression reduced both ROS and cell death in this model system. We conclude that GST overexpression may be an important part of a protective strategy against ACT and that this model system will aid in defining steps in the pathway(s) leading to AC-induced cell death that can be therapeutically manipulated.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. D. Venkatakrishnan, K. Dunsmore, H. Wong, S. Roy, C. K. Sen, A. Wani, J. L. Zweier, and G. Ilangovan
HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1736 - H1744.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Turakhia, C. D. Venkatakrishnan, K. Dunsmore, H. Wong, P. Kuppusamy, J. L. Zweier, and G. Ilangovan
Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3111 - H3121.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang
Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells
Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. D. Venkatakrishnan, A. K. Tewari, L. Moldovan, A. J. Cardounel, J. L. Zweier, P. Kuppusamy, and G. Ilangovan
Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2680 - H2691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. L'Ecuyer, S. Sanjeev, R. Thomas, R. Novak, L. Das, W. Campbell, and R. V. Heide
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1273 - H1280.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. C. Chua, X. Liu, J. Gao, R. C. Hamdy, and B. H. L. Chua
Multiple actions of pifithrin-{alpha} on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2606 - H2613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. Ilangovan, C. D. Venkatakrishnan, A. Bratasz, S. Osinbowale, A. J. Cardounel, J. L. Zweier, and P. Kuppusamy
Heat shock-induced attenuation of hydroxyl radical generation and mitochondrial aconitase activity in cardiac H9c2 cells
Am J Physiol Cell Physiol, February 1, 2006; 290(2): C313 - C324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. Ilangovan, S. Osinbowale, A. Bratasz, M. Bonar, A. J. Cardounel, J. L. Zweier, and P. Kuppusamy
Heat shock regulates the respiration of cardiac H9c2 cells through upregulation of nitric oxide synthase
Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1472 - C1481.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.